Results 171 to 180 of about 5,407,498 (292)
ABSTRACT Treatment of sarcoma includes high‐dose anthracyclines, which can cause cardiotoxicity. This study assesses the correlation of cardiac biomarkers and echocardiographic parameters on asymptomatic cardiotoxicity in sarcoma patients treated with anthracyclines.
Elissa A. S. Polomski +6 more
wiley +1 more source
Neuroinflammation causes mitral cell dysfunction and olfactory impairment in a multiple sclerosis model. [PDF]
Schubert C +12 more
europepmc +1 more source
No differences were noted between pulsed field ablation and cryoballoon ablation regarding mechanical properties of the left atrium, assessed by invasively acquired P–V relationship, following first‐time ablation for atrial fibrillation. ABSTRACT Background Acute effects of pulsed field ablation (PFA) on passive atrial mechanical properties have not ...
Christos‐Konstantinos Antoniou +9 more
wiley +1 more source
CCKergic Tufted Cells Regulate Odor Sensitivity by Controlling Mitral Cell Output in the Mouse Olfactory Bulb. [PDF]
Starr E +7 more
europepmc +1 more source
A 79‐year‐old woman with lifelong peripheral edema and an affected sister was found to harbor a novel homozygous THSD1 splice‐site variant. Reduced THSD1 expression in dermal endothelial cells supported the possibility that this variant contributes to chronic hereditary edema.
Eiko Amo +23 more
wiley +1 more source
Mitral Cell Dendritic Morphology in the Adult Zebrafish Olfactory Bulb following Growth, Injury and Recovery. [PDF]
Rozofsky JP, Pozzuto JM, Byrd-Jacobs CA.
europepmc +1 more source
The evaluation of the endocranial anatomy of 43 crocodylian species reveals several differences, including variation in the curvature of the encephalic endocast, the size of the endosseous labyrinth and paratympanic sinuses, and the presence of additional snout sinuses.
Paul M. J. Burke, Philip D. Mannion
wiley +1 more source
Suppression of BMP signaling restores mitral cell development impaired by FGF signaling deficits in mouse olfactory bulb. [PDF]
Ito A, Miller C, Imamura F.
europepmc +1 more source
ABSTRACT Background Pediatric thromboembolism is increasingly encountered in critical care. Systemic thrombolysis with tissue plasminogen activator (tPA) facilitates vessel or valve patency, yet pediatric‐specific protocols remain undefined, and safety concerns persist. Objective To evaluate the efficacy and safety of a tailored, prolonged systemic tPA
Eran Shostak +5 more
wiley +1 more source
Objective To characterize the clinical features, treatment, and outcomes of a large, international cohort of childhood‐onset Takayasu arteritis (cTAK). Methods Patients with a diagnosis of cTAK were identified in A Registry of Childhood Vasculitis and divided into subcohorts by era‐of diagnosis: pre‐biologic (PB; 1986–2006), early biologic (EB; 2007 ...
James Bistolarides +29 more
wiley +1 more source

